The company’s gross profit for the quarter was $3.5 million — up 31 percent from the year before. Fuse’s net income also increased by $630,524.
Fuse’s growth plan for 2023 and 2024 is to focus on the design and development of new orthopedic and spinal devices for commercialization and expand its national distribution footprint, according to an Aug. 15 press release.
